✦ LIBER ✦

Seroprevalence of HTLV-1 in chronic disease patients in Jamaica

✍ Scribed by E.N. Barton; O.St C. Morgan; M.F. Smikle; W.A. Blattner

Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 307 KB
Volume: 88
Category: Article
ISSN: 0035-9203
DOI: 10.1016/0035-9203(94)90403-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Seroprevalence of antibodies to HTLV-I I

Seroprevalence of antibodies to HTLV-I In patients with chronic neurological disorders other than tropical spastic paraparesis

✍ Dr. Carlos A. Mora; Ralph M. Garruto; Paul Brown; Don Guiroy; Owen St. C. Morgan 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB 👁 2 views

Seroprevalence of hepatitis C virus nucl

Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease

✍ Dr. Jonathan Brown; Spyros Dourakis; Peter Karayiannis; Robert Goldin; Joe Chiba 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

The serological responses to two different hepatitis C virus antigens were studied by enzyme-linked immunosorbent assay in a variety of chronic liver diseases and in healthy blood donors. The study population comprised 97 cases of cryptogenic chronic liver disease (40% with a history suggestive of p

Superoxide dismutase type 1 in monocytes

Superoxide dismutase type 1 in monocytes of chronic kidney disease patients

✍ Alexandra Scholze; Katharina Krueger; Madeleine Diedrich; Christine Räth; Anja T 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 720 KB

Immunohistochemical characteristics of p

Immunohistochemical characteristics of polymyositis in patients with HTLV-1–associated myelopathy and HTLV-I carriers

✍ Dr. Itsuro Higuchi; Dr. Elizabeth S. Montemayor; Dr. Syuji Izumo; Dr. Masaru Ino 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 502 KB

HTLV-I-specific cytotoxic T lymphocytes

HTLV-I-specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-I-associated neurological disease

✍ Dr. Steven Jacobson; Dale E. McFarlin; Susan Robinson; Rhonda Voskuhl; Roland Ma 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

Pharmacokinetics of isradipine in patien

Pharmacokinetics of isradipine in patients with chronic liver disease

✍ J. Cotting; J. Reichen; K. Kutz; R. Laplanche; E. Nüesch 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 523 KB

The pharmacokinetics of the dihydropyridine calcium antagonist isradipine has been examined in 8 healthy volunteers, 7 patients with non-cirrhotic chronic liver disease (CLD), and 8 patients with biopsy-proven cirrhosis (CIR). Isradipine was simultaneously given orally (12C 5 mg) and i.v. (13C 1 mg)